Caseware UK (AP4) 2022.0.179 2022.0.179 2023-08-312023-08-312022-09-01falsefalseNo description of principal activity4648true 02396001 2022-09-01 2023-08-31 02396001 2021-09-01 2022-08-31 02396001 2023-08-31 02396001 2022-08-31 02396001 c:Director1 2022-09-01 2023-08-31 02396001 d:Buildings 2022-09-01 2023-08-31 02396001 d:Buildings 2023-08-31 02396001 d:Buildings 2022-08-31 02396001 d:Buildings d:OwnedOrFreeholdAssets 2022-09-01 2023-08-31 02396001 d:Buildings d:LongLeaseholdAssets 2022-09-01 2023-08-31 02396001 d:Buildings d:LongLeaseholdAssets 2023-08-31 02396001 d:Buildings d:LongLeaseholdAssets 2022-08-31 02396001 d:Buildings d:ShortLeaseholdAssets 2022-09-01 2023-08-31 02396001 d:Buildings d:ShortLeaseholdAssets 2023-08-31 02396001 d:Buildings d:ShortLeaseholdAssets 2022-08-31 02396001 d:LandBuildings 2023-08-31 02396001 d:LandBuildings 2022-08-31 02396001 d:PlantMachinery 2022-09-01 2023-08-31 02396001 d:PlantMachinery 2023-08-31 02396001 d:PlantMachinery 2022-08-31 02396001 d:PlantMachinery d:OwnedOrFreeholdAssets 2022-09-01 2023-08-31 02396001 d:FurnitureFittings 2022-09-01 2023-08-31 02396001 d:FurnitureFittings 2023-08-31 02396001 d:FurnitureFittings 2022-08-31 02396001 d:FurnitureFittings d:OwnedOrFreeholdAssets 2022-09-01 2023-08-31 02396001 d:OwnedOrFreeholdAssets 2022-09-01 2023-08-31 02396001 d:CurrentFinancialInstruments 2023-08-31 02396001 d:CurrentFinancialInstruments 2022-08-31 02396001 d:Non-currentFinancialInstruments 2023-08-31 02396001 d:Non-currentFinancialInstruments 2022-08-31 02396001 d:CurrentFinancialInstruments d:WithinOneYear 2023-08-31 02396001 d:CurrentFinancialInstruments d:WithinOneYear 2022-08-31 02396001 d:Non-currentFinancialInstruments d:AfterOneYear 2023-08-31 02396001 d:Non-currentFinancialInstruments d:AfterOneYear 2022-08-31 02396001 d:ShareCapital 2023-08-31 02396001 d:ShareCapital 2022-08-31 02396001 d:RetainedEarningsAccumulatedLosses 2023-08-31 02396001 d:RetainedEarningsAccumulatedLosses 2022-08-31 02396001 d:AcceleratedTaxDepreciationDeferredTax 2023-08-31 02396001 d:AcceleratedTaxDepreciationDeferredTax 2022-08-31 02396001 d:TaxLossesCarry-forwardsDeferredTax 2023-08-31 02396001 d:TaxLossesCarry-forwardsDeferredTax 2022-08-31 02396001 c:OrdinaryShareClass1 2022-09-01 2023-08-31 02396001 c:OrdinaryShareClass1 2023-08-31 02396001 c:OrdinaryShareClass1 2022-08-31 02396001 c:FRS102 2022-09-01 2023-08-31 02396001 c:Audited 2022-09-01 2023-08-31 02396001 c:FullAccounts 2022-09-01 2023-08-31 02396001 c:PrivateLimitedCompanyLtd 2022-09-01 2023-08-31 02396001 c:SmallCompaniesRegimeForAccounts 2022-09-01 2023-08-31 02396001 2 2022-09-01 2023-08-31 02396001 7 2022-09-01 2023-08-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 02396001










JAPAN GREEN MEDICAL CENTRE LIMITED










FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 AUGUST 2023

 
JAPAN GREEN MEDICAL CENTRE LIMITED
REGISTERED NUMBER: 02396001

BALANCE SHEET
AS AT 31 AUGUST 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
451,313
432,274

  
451,313
432,274

Current assets
  

Stocks
 5 
34,669
30,541

Debtors: amounts falling due after more than one year
 6 
94,787
94,787

Debtors: amounts falling due within one year
 6 
844,972
822,639

Cash at bank and in hand
 7 
1,332,127
804,069

  
2,306,555
1,752,036

Creditors: amounts falling due within one year
 8 
(346,849)
(276,786)

Net current assets
  
 
 
1,959,706
 
 
1,475,250

Total assets less current liabilities
  
2,411,019
1,907,524

Creditors: amounts falling due after more than one year
 9 
(600,000)
(600,000)

Provisions for liabilities
  

Deferred tax
 10 
(42,411)
(33,999)

  
 
 
(42,411)
 
 
(33,999)

Net assets
  
1,768,608
1,273,525


Capital and reserves
  

Called up share capital 
 11 
2,000,000
2,000,000

Profit and loss account
  
(231,392)
(726,475)

  
1,768,608
1,273,525


Page 1

 
JAPAN GREEN MEDICAL CENTRE LIMITED
REGISTERED NUMBER: 02396001
    
BALANCE SHEET (CONTINUED)
AS AT 31 AUGUST 2023

The Company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 17 November 2023.




Dr Y Takaya
Director

The notes on pages 3 to 11 form part of these financial statements.

Page 2

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

1.


General information

Japan Green Medical Centre Limited is a private company limited by shares, registered in England. The address of registered office is Basement, 10 Throgmorton Avenue, London, EC2N 2DL.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The current economic conditions continue to create worldwide uncertainty over trading performance. The Company’s forecasts and projections, taking account of reasonably possible changes in trading performance, show that it should be able to operate within the level of its current financing arrangements. After making enquiries, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. The directors, having made sufficient enquiries, are satisfied that the ultimate parent company pledged to provide financial support in terms of contributing towards potential liquidity and working capital shortfalls. The Company therefore continues to adopt the going concern basis in preparing its financial statements.

 
2.3

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of Comprehensive Income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

2.Accounting policies (continued)

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.5

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.6

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.7

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.8

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 4

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

2.Accounting policies (continued)

 
2.9

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.10

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.11

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 5

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

2.Accounting policies (continued)


2.11
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Freehold property
-
Building element over 30 years
Long-term leasehold property
-
20%
Short-term leasehold property
-
20%
Plant and machinery
-
20%
Fixtures and fittings
-
20%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.12

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.13

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.14

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.15

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 6

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

2.Accounting policies (continued)

 
2.16

Holiday pay accrual

A liability is recognised to the extent of any unused holiday pay entitlement which is accrued at the balance sheet date and carried forward to future periods. This is measured at the undiscounted salary cost of the future holiday entitlement so accrued at the balance sheet date.

 
2.17

Provisions for liabilities

Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance Sheet.

 
2.18

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Comprehensive Income.


3.


Employees

The average monthly number of employees, including the directors, during the year was as follows:


        2023
        2022
            No.
            No.







Average number of employees
46
48

Page 7

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

4.


Tangible fixed assets





Freehold property
Long-term leasehold property
Short-term leasehold property
Plant and machinery
Fixtures and fittings
Total

£
£
£
£
£
£



Cost or valuation


At 1 September 2022
306,005
417,703
122,968
356,486
223,395
1,426,557


Additions
-
-
-
17,352
44,283
61,635



At 31 August 2023

306,005
417,703
122,968
373,838
267,678
1,488,192



Depreciation


At 1 September 2022
68,643
417,703
122,968
231,944
153,025
994,283


Charge for the year on owned assets
4,239
-
-
12,240
26,117
42,596



At 31 August 2023

72,882
417,703
122,968
244,184
179,142
1,036,879



Net book value



At 31 August 2023
233,123
-
-
129,654
88,536
451,313



At 31 August 2022
237,362
-
-
124,542
70,370
432,274




The net book value of land and buildings may be further analysed as follows:


2023
2022
£
£

Freehold
233,123
237,362

233,123
237,362



5.


Stocks

2023
2022
£
£

Finished goods and goods for resale
34,669
30,541

34,669
30,541


Page 8

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

6.


Debtors

2023
2022
£
£

Due after more than one year

Other debtors
94,787
94,787

94,787
94,787


2023
2022
£
£

Due within one year

Trade debtors
538,880
579,835

Other debtors
24,809
22,595

Prepayments and accrued income
281,283
220,209

844,972
822,639



7.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
1,332,127
804,069

1,332,127
804,069


The Bankers of the Company have a legal charge over the deposits and the Freehold Property of the Company.


8.


Creditors: Amounts falling due within one year

2023
2022
£
£

Trade creditors
89,135
152,249

Corporation tax
125,305
-

Other taxation and social security
52,919
56,753

Other creditors
7,278
11,416

Accruals and deferred income
72,212
56,368

346,849
276,786


Page 9

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

9.


Creditors: Amounts falling due after more than one year

2023
2022
£
£

Loan from parent undertaking
600,000
600,000

600,000
600,000


The loan is an intercompany loan at an interest of 2.1% (reviewed annually) and payable by 31 March 2025.


10.


Deferred taxation




2023


£






At beginning of year
(33,999)


Charged to profit or loss
(8,412)



At end of year
(42,411)

The provision for deferred taxation is made up as follows:

2023
2022
£
£


Accelerated capital allowances
(42,411)
(45,343)

Tax losses carried forward
-
11,344

(42,411)
(33,999)


11.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



2,000,000 (2022 - 2,000,000) Ordinary shares of £1.00 each
2,000,000
2,000,000


Page 10

 
JAPAN GREEN MEDICAL CENTRE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023

12.


Capital commitments


At 31 August 2023 the Company had capital commitments as follows:

2023
2022
£
£


X-ray machine - contracted for but not provided in these financial statements
283,916
-

283,916
-


13.


Pension commitments

The Company operates a defined contributions pension sheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. There is no contributions payable to the fund at the balance sheet date.


14.


Other financial commitments

As at the balance sheet date, the Company had other financial commitments with a supplier  as follows:


2023
2022
£
£



Not later than 1 year
23,291
16,455

Later than 1 year and not later than 5 years
69,872
16,455

93,163
32,910




15.


Controlling party

The immediate and ultimate parent undertaking is JGH. Holdings Pte Ltd registered in Singapore. 
 
The smallest and largest group of which the Company is a member of and which prepares consolidated accounts is JGH Holdings Pte Ltd. The address of registered office of JGH. Holdings Pte Ltd is 290 Orchard Road, #10-01 Paragon, Singapore 238859


16.


Auditors' information

The auditors' report on the financial statements for the year ended 31 August 2023 was unqualified.

The audit report was signed on 17 November 2023 by Yusuke Takanishi (Senior Statutory Auditor) on behalf of Greenback Alan LLP.

Page 11